Betta Pharmaceuticals Statistics
Total Valuation
Betta Pharmaceuticals has a market cap or net worth of CNY 15.44 billion. The enterprise value is 17.42 billion.
Market Cap | 15.44B |
Enterprise Value | 17.42B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | Jun 6, 2024 |
Share Statistics
Betta Pharmaceuticals has 418.49 million shares outstanding. The number of shares has decreased by -0.73% in one year.
Shares Outstanding | 418.49M |
Shares Change (YoY) | -0.73% |
Shares Change (QoQ) | -5.62% |
Owned by Insiders (%) | 3.78% |
Owned by Institutions (%) | 14.38% |
Float | 229.56M |
Valuation Ratios
The trailing PE ratio is 36.51 and the forward PE ratio is 27.74. Betta Pharmaceuticals's PEG ratio is 0.92.
PE Ratio | 36.51 |
Forward PE | 27.74 |
PS Ratio | 5.85 |
PB Ratio | 2.82 |
P/FCF Ratio | 94.12 |
PEG Ratio | 0.92 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.77, with an EV/FCF ratio of 106.19.
EV / Earnings | 41.12 |
EV / Sales | 6.59 |
EV / EBITDA | 22.77 |
EV / EBIT | 40.09 |
EV / FCF | 106.19 |
Financial Position
The company has a current ratio of 0.70, with a Debt / Equity ratio of 42.31.
Current Ratio | 0.70 |
Quick Ratio | 0.40 |
Debt / Equity | 42.31 |
Debt / EBITDA | 3.10 |
Debt / FCF | 14.35 |
Interest Coverage | 9.09 |
Financial Efficiency
Return on equity (ROE) is 7.61% and return on invested capital (ROIC) is 3.50%.
Return on Equity (ROE) | 7.61% |
Return on Assets (ROA) | 3.02% |
Return on Capital (ROIC) | 3.50% |
Revenue Per Employee | 1.35M |
Profits Per Employee | 216,050 |
Employee Count | 1,961 |
Asset Turnover | 0.30 |
Inventory Turnover | 1.28 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.85% in the last 52 weeks. The beta is 0.71, so Betta Pharmaceuticals's price volatility has been lower than the market average.
Beta (5Y) | 0.71 |
52-Week Price Change | -22.85% |
50-Day Moving Average | 33.74 |
200-Day Moving Average | 41.63 |
Relative Strength Index (RSI) | 62.70 |
Average Volume (20 Days) | 6,839,032 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Betta Pharmaceuticals had revenue of CNY 2.64 billion and earned 423.67 million in profits. Earnings per share was 1.01.
Revenue | 2.64B |
Gross Profit | 2.20B |
Operating Income | 429.44M |
Pretax Income | 429.95M |
Net Income | 423.67M |
EBITDA | 753.01M |
EBIT | 429.44M |
Earnings Per Share (EPS) | 1.01 |
Balance Sheet
The company has 465.45 million in cash and 2.35 billion in debt, giving a net cash position of -1.89 billion or -4.51 per share.
Cash & Cash Equivalents | 465.45M |
Total Debt | 2.35B |
Net Cash | -1.89B |
Net Cash Per Share | -4.51 |
Equity (Book Value) | 5.56B |
Book Value Per Share | 13.07 |
Working Capital | -506.67M |
Cash Flow
In the last 12 months, operating cash flow was 1.08 billion and capital expenditures -911.49 million, giving a free cash flow of 164.07 million.
Operating Cash Flow | 1.08B |
Capital Expenditures | -911.49M |
Free Cash Flow | 164.07M |
FCF Per Share | 0.39 |
Margins
Gross margin is 83.39%, with operating and profit margins of 16.25% and 16.03%.
Gross Margin | 83.39% |
Operating Margin | 16.25% |
Pretax Margin | 16.27% |
Profit Margin | 16.03% |
EBITDA Margin | 28.49% |
EBIT Margin | 16.25% |
FCF Margin | 6.21% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.46%.
Dividend Per Share | 0.17 |
Dividend Yield | 0.46% |
Dividend Growth (YoY) | 142.86% |
Years of Dividend Growth | n/a |
Payout Ratio | 34.69% |
Buyback Yield | 0.73% |
Shareholder Yield | 1.18% |
Earnings Yield | 2.74% |
FCF Yield | 1.06% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |